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ABSTRACT
Objective: Partial knee endoprosthesis to bone sarco-
mas resections seems to be a good solution to treat this 
immature skeletal patients. The purpose of this study 
is to evaluate the functional score in fourteen patients, 
advantages and the technique indications. Methods: Re-
trospective analysis was done to assess in this group of 
patients the functional evolution and the possible com-
plications of the procedure. 14 patients between 10 and 
22 years functionally evaluated in Ennekin/ISOLS (In-
ternational Society of Limb Salvage) criteria, being all 
of them operated in the same institution by the same 
surgeon. Were used distal femur and proximal tibia par-
tial endoprosthesis. Results: General analysis demonstra-
ted that the functional results were over than 67 percent 
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INTRODUCTION
The most common primary malignant bone tumors 
in childhood and adolescence are osteosarcoma and 
Ewing’s sarcoma. The distal femur and the proximal 
tibia are two of the main sites of localization. These 
localizations often compromise the knee joint, requi-
ring limb salvage surgery to replace segments with 
endoprostheses. Several models of endoprostheses are 
available for various indications in surgical resection 
of bone tumors of the knee(1). However, in cases whe-
re the tumor does not respect the limits of the growth 
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(ISOLS criteria) in 78,6 percent of the patients, being 
considered excellent. 21,4 percent were considered good 
results, being between 50 and 66 percent. Bone stora-
ge was preserved when avoiding the adjacent segment 
resection. Surgery time was not prolonged in ligament 
reconstruction. Conclusion: Knee partial endoprosthesis 
are less damage to bone storage in young patients. The 
critics about the bad functional results are being supplied 
by new surgical techniques, excellent rehabilitation pro-
tocols, implants technology and the consequent learning 
curve. This option of treatment permits the preservation 
of healthy bone and provides the possibility of a revision 
replacement less aggressive.
Keywords – Knee; Sarcoma Ewing’s; Osteosarcoma; 
Knee prosthesis; Retrospective studies
cartilage, invading the epiphysis of the long bones of 
the knee joint without joint invasion, it is possible to 
indicate resection with partial replacement by endo-
prosthesis. This technique allows en bloc resection 
of the distal femur or proximal tibia, preserves the 
adjacent joint epiphysis, and the implant replaces only 
the affected segment of the femur or tibia.
The use of partial endoprostheses is limited to pa-
tients with tumors with the characteristics described 
above and in the skeletally immature age group be-
tween 10 to 16 years. Individuals aged between 17 
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and Ewing protocols who underwent resection of the 
distal femur or proximal tibia due to primary bone 
tumors with replacement by non-articulating partial 
knee endoprosthesis and ligament reconstruction were 
evaluated retrospectively.
Surgical indication was based on morphological 
characteristics of the tumor in the knee, that is, tumors 
located in the distal femur or proximal tibia with in-
vasion of the growth cartilage and epiphysis, but no 
joint involvement visible on MRI. The presence of 
lung metastases was not an exclusion criterion.
All cases were operated with oncological criteria in 
the period between February 2003 and February 2008 
in the same institution and by the same surgeon. The 
14 patients had free surgical margins on pathological 
examination.
The implants of choice were: non-articulating par-
tial distal femoral endoprosthesis (IMPOL®) for tu-
mors of the distal femur and non-articulating partial 
distal tibial endoprosthesis (IMPOL®) for cancers of 
the proximal tibia. The articular surface of the implant 
is made of a chromium-cobalt-molybdenum alloy, 
minimizing friction with the normal cartilage of the 
adjacent segment. The body of the endoprosthesis was 
made of ultra high molecular weight polyethylene and 
the femoral or tibial stem was made of titanium alloy. 
The fixation of the implant to the bone was made with 
radiopaque bone cement.
Functional evaluation was based on a score as pro-
posed by Enneking et al.(11) The score is based on six 
variables (pain, function, emotional acceptance, use 
of support such as canes or crutches, walking, and 
running), with each assigned a maximum of 5 points. 
The total sum can be up to 30 points. The patient’s 
number of points is then divided by the maximum 
value (30 points). The percentage is then expressed 
as follows: excellent (67%-100%), good (50%-66%) 
and poor (< 50%) according to at least six months 
postoperative follow-up. All patients were instructed 
to remain with a private instructor postoperatively 
for a period of 60 to 90 days without load-bearing 
and, afterwards, to follow a rehabilitation protocol for 
gaining range of motion, proprioception, and muscle 
strengthening included by the authors(12, 13).
Quantitative variables were described by mean ± 
standard deviation and qualitative variables by abso-
lute and relative frequencies.
To evaluate possible associations between
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and 22 years also benefit from partial endoprostheses 
due to bone stock preservation and residual growth 
until near the age limit of 22 years(2). Very young 
patients who have not yet started the second growth 
spurt and undergo replacement with an implant in the 
lower limbs will present discrepancies incompatible 
with the functionality of the lower extremity over the 
years. In our opinion, radical surgery (amputation) is 
more prudent in these cases. Yet in individuals who 
have completed growth, the benefits of preserving the 
epiphyseal region are much smaller, and total knee 
endoprosthesis is more suitable(3,4).
In the not too distant past, primary malignant bone 
tumor resection with an oncologic margin during chil-
dhood and adolescence was synonymous with limb 
amputation. The development of new surgical tech-
niques, better hospital conditions, the introduction of 
neoadjuvant chemotherapy with well-defined proto-
cols, the improvement of the types of implants and the 
surgical learning curve for orthopedic surgeons have 
provided more security and better quality of life for 
patients with these diseases(3,5-9).
The increase in disease-free survival and tumor 
cure for tumors such as Ewing’s sarcoma and osteo-
sarcoma brought concern for the life of the implant 
used(10). In young patients, implants such as total knee 
endoprosthesis have the disadvantage of requiring 
resection or femoral/tibial osteotomy for fixation of 
the implant to the adjacent segment, and therefore 
the removal of the meta-epiphyseal area of growth. 
This implies a discrepancy in the growth of the lower 
extremities, decreased bone stock, and future compli-
cations for revision of the implant due to cementation 
and resection of bone not affected by the tumor.
In order to reduce complications such as those 
described and evaluate the functionality and charac-
teristics of patients to this exceptional indication, we 
analyzed the cases where non-articulating partial knee 
implants were used (partial endoprostheses) in young 
patients, associated with ligament reconstruction in 
resections with oncological margins in the distal fe-
mur and proximal tibia.
METHODS
All patients were operated by the orthopedic on-
cology group of the Hospital de Câncer de Barre-
tos, São Paulo. Fourteen patients aged between 10 
and 22 years included in the Brazilian Osteosarcoma 
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categorical variables the Fisher’s exact test was used. 
The Student’s t-test was used to compare means.
 !"#!$%!&!'('")!*+,+*!-.!/0120.03423+!54/!46-%7+6!
and analyses were performed using SPSS (Statistical 
Package for the Social Sciences) version 13.0.
In the 14 patients evaluated, the mean age was 
13.5 ± 3.5 years. Regarding gender, 10 patients 
(71.4%) were female and four (28.6%) were male. 
In this group, osteosarcoma appeared in twelve of 
the patients (85.7%), while one (7.1%) belonged 
to the Ewing’s sarcoma group, and one (7.1%) was 
diagnosed with malignant fibrous histiocytoma
(treatment protocol equal to the osteosarcoma). Nine 
tumors (64.3%) were located in the distal femur and 
five (35.7%) were in the proximal tibia. Most pa-
tients (57.1%) were from the state of São Paulo. 
The study was approved by the Research Ethics 
Committee of the Hospital de Câncer de Barretos, 
Fundação Pio XII.
RESULTS
Data analysis showed that eleven patients (78.6%) 
had an excellent Enneking score, and three (21.4%) 
had good results. The presence of complications was 
low, and all resolved in the early postoperative pe-
riod. Of the 14 patients, nine showed no arthroplasty 
complications; one had a superficial infection; one 
had joint instability with subluxation, probably due 
to very early removal of immobilization in the city 
of origin; three others developed complications such 
as pressure ulcers and patellar tendon rupture in the 
tibial prosthesis. Of the patients with a good score, 
100% had postoperative complications (p = 0.027), 
so the complications during the course of treatment 
decreased the functionality of the knee (Chart 1).
The average time of immobilization was 9.76 ± 
3.3 weeks (maximum of 16.4 and minimum of 3.8 
weeks) and average patient follow-up period was 23.1 
± 15.8 months (maximum of 68.2 and minimum of 
2.2 months). We found that the group with the longest 
time of immobilization had the best functional score 
(p = 0.048) (Chart 2).
We did not find a statistical correlation between the 
patients’ age and functional score. Younger individuals 
did not have better knee function.
The location of the tumor in the proximal tibia or 
distal femur was not responsible for variations in the 
Enneking score with any statistical significance.
Chart 1 – Association between the Enneking score and the 
incidence of complications (p = 0.027).
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During patient follow-up, we identified eleven 
(78.6%) who are living and three (21.4%) who died 
due to disease progression (Table 1).
DISCUSSION
The introduction of neoadjuvant chemotherapy in 
the 1980s greatly increased the possibility of tumor 
resection with limb preservation. Over 80% of pa-
tients with osteosarcoma of the extremities become 
candidates for limb salvage surgery(3). Limb salvage 
surgery for bulky primary bone tumors require large 
resection of the knee and create significant segmental 
defects that require some kind of replacement that pre-
serves the functionality of the joint (Figures 1 and 2).
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Chart 2 – Evaluation of the average time of immobilization 
according to the Enneking score (p = 0.048).
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The replacement methods may vary greatly, and 
among them are biological options such as using free 
or vascularized grafts from the patient or other indi-
viduals (allograft). Other options include distal femo-
ral and proximal tibial endoprostheses. Among the 
different endoprostheses available on the market are 
the hinged, rotatory, and those used for arthrodesis. 
Some use cement for femoral fixation and others are 
fixed by press-fit(4).
The indication for surgery for tumors located in the 
distal femur and proximal tibia depends on the ana-
tomical relationship of the tumor with the structures 
that are part of the normal knee. Tumors invading 
the knee joint make the patient a candidate for extra-
articular resection with or without arthrodesis, and 
consequently, partial or total functional restriction. 
Neoplasias that do not invade the joint but compro-
mise the growth cartilage and epiphysis reduce the 
number of surgical alternatives and require the ortho-
pedic surgeon to resort to more specific procedures. 
Among them, osteoarticular allograft was described 
as a good alternative in a study performed by Muscolo 
et al.(14) with 80 patients with tumors in the distal fe-
mur subjected to this method and followed up for five 
to 10 years. This alternative, however, is described by 
many authors as having complications such as graft 
fracture, pseudoarthrosis, infection, and osteoarthritis 
secondary to condylar osteonecrosis(15-17).Figure 1 – X-ray of the knee.
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Table 1 – Sample characteristics.
Variables n=14
Age (years) – Mean ± SD 13.5 ± 3.6
Gender – n (%)
Male 4 (28.6)
Female 10 (71.4)
Type of tumor – n (%)
Osteossarcoma 12 (85.7)
Ewing's sarcoma 1 (7.1)
MFH 1 (7.1)
Location of tumor – n (%)
Femur 9 (64.3)
Proximal tibia 5 (35.7)
Enneking/ISOLS score – n (%)
Excellent 11 (78.6)
Good 3 (21.4)
Complications – n (%)
No complications 9 (64.3)
Infection 1 (7.1)
Instability 1 (7.1)
Other 3 (21.4)
Time of immobilization (weeks) – 
Mean ± SD 9.76 ± 3.3
Follow-up period (months) –
Mean ± SD 23.1 ± 15.8
Current status – n (%)
Living 11 (78.6)
Deceased 3 (21.4)
Figure 2 – Cut piece.
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An option that has long been used for tumors lo-
cated in the knees of young patients is the hinged 
total endoprosthesis for the distal femur and proximal 
tibia. This implant provides stability, a faster return 
to activities, and better quality of life to patients with 
bone tumors. However, in skeletally immature pa-
tients, its use compromises the epiphysis of adjacent 
bone, resulting in decreased bone stock and a greater 
discrepancy between the lower limbs. The indication 
for this type of implant is better suited for individuals 
who do not have any more open growth cartilage 
or who are at least already at the end of the second 
growth spurt(2-4,18).
In this study, we opted for an implant that replaced 
only the distal femur or proximal tibia (Figures 3, 4 
and 5). All patients had tumor invasion of the growth 
cartilage without penetration into the joint cavity or ex-
tension to the cruciate ligaments. The implant allowed 
for the preservation of the epiphysis of the adjacent 
bone (tibia or femur), reducing the risk of discrepancy 
or future problems with little bone stock for prosthetic 
revision. Cruciate and collateral ligament reconstruc-
tion was necessary, in addition to patellar tendon re-
construction in proximal tibial replacement. Despite 
the need for the reconstruction of ligaments, surgical 
time remained very similar to that for total knee en-
doprosthesis because no time was used for osteotomy 
of the adjacent segment.
There are no articles in the literature that eva-
luate the partial implant apart from total knee en-
doprostheses. The method has a number of advan-
tages over hinged implants in skeletally immature 
patients. Clinically, the dynamic gait evaluation 
is very similar to non-conventional total knee
arthroplasties(19,20). Although there is some degree 
of static hyperlaxity, there is no instability in the 
standing position or walking. Muscular action in 
the stance and swing phases keeps the knee stable. 
This study of 14 patients shows excellent functio-
nal assessment results, with those individuals who 
developed complications had lower scores. In vivo 
biomechanical gait analysis of partial endopros-
theses still requires more refined research, and 
this study in the Hospital de Câncer de Barretos 
is one of the first steps in the validation of this 
surgical technique.
CONCLUSION
Partial knee endoprostheses provide the orthopedic 
surgeon and the patient a method of limb salvage with 
excellent functionality, maintenance of bone stock for 
revision, and reduction of discrepancies in skeletally 
immature individuals.
Figure 3 – Fabroni-type unconventional endoprosthesis. 
Figure 4 – Joint reconstruction.
Figura 5 – Raio X controle
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